Showing results (11-20 of 147) with videos related to
Sort By:
Pageof 15
Asia-Pacific Journal of Clinical Oncology|June 28, 2021
Hospitalizations in solid tumor phase I clinical trial patients: Incidence, pattern and clinical outcomes at an Australian phase I clinical trial unitLinda Ye, Mihitha Ariyapperuma, Angela Jacques, et al.Plos One|June 2, 2015
Secreted frizzled-related protein 4 inhibits glioma stem-like cells by reversing epithelial to mesenchymal transition, inducing apoptosis and decreasing cancer stem cell propertiesG Bhuvanalakshmi, Frank Arfuso, Michael Millward, et al.Cancer Letters|July 9, 2017
Circulating tumour DNA (ctDNA) as a liquid biopsy for melanomaLeslie Calapre, Lydia Warburton, Michael Millward, et al.Cancers|September 14, 2024
HLA-A01 and HLA-B27 Supertypes, but Not HLA Homozygocity, Correlate with Clinical Outcome among Patients with Non-Small Cell Lung Cancer Treated with Pembrolizumab in Combination with ChemotherapyAfaf Abed, Anna Reid, Ngie Law, et al.Cancers|July 3, 2019
Is the Blood an Alternative for Programmed Cell Death Ligand 1 Assessment in Non-Small Cell Lung Cancer?Emmanuel Acheampong, Isaac Spencer, Weitao Lin, et al.Asia-Pacific Journal of Clinical Oncology|May 19, 2011
Small cell lung cancer presenting with paraneoplastic limbic encephalitisSamantha Bowyer, Suzanne Webb, Michael Millward, et al.Oncology Research|January 11, 2014
Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cellsSudha Warrier, Senthil Kumar Balu, Alan Prem Kumar, et al.Journal of Translational Medicine|September 18, 2012
Evaluation of a multi-marker immunomagnetic enrichment assay for the quantification of circulating melanoma cellsJames B Freeman, Elin S Gray, Michael Millward, et al.Frontiers in Oncology|January 5, 2024
Detectable ctDNA at the time of treatment cessation of ipilimumab and nivolumab for toxicity predicts disease progression in advanced melanoma patientsLydia Warburton, Anna Reid, Benhur Amanuel, et al.The American Journal of Dermatopathology|November 22, 2016
Cutaneous Metastatic Melanoma Resembling a Halo Nevus, in the Setting of PD-1 InhibitionNathan Tobias Harvey, Michael Millward, Kirstie Macgregor, et al.Pageof 15